Research programme: galectin modulators - Galecto BiotechAlternative Names: Galectin activators - Galecto Biotech; Galectin inhibitors - Galecto Biotech; Galectin-3 inhibitors - Galecto Biotech
Latest Information Update: 05 Nov 2014
At a glance
- Originator Galecto Biotech
- Class Small molecules
- Mechanism of Action Galectin modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Fibrosis; Inflammation